← Back to headlines
McKinsey to Pay $125 Million to Purdue Bankruptcy Over Opioid Sales Advice
Consulting firm McKinsey & Company has agreed to contribute $125 million to the Purdue Pharma bankruptcy trust, settling claims related to its advisory role in the pharmaceutical company's opioid sales practices.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
